Study guide

Wernicke disease, opioids and stimulants

AMC CAT MCQ Examination AMC Part 1

Track your progress as you read

Finished sections get a check mark.

1 Acute Coronary Syndromes & ECG Localization

ACS recognition and ECG localisation Reperfusion and infarction complications

2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias

Heart failure assessment and treatment Arrhythmias and conduction emergencies

3 Systemic Hypertension & Peripheral Vascular Disease

Blood pressure and cardiovascular risk Secondary hypertension and arterial disease

4 Valvular Heart Disease, Infective Endocarditis & Pericarditis

Aortic and mitral valve disease Endocarditis and pericardial emergencies

5 Asthma & COPD Acute Flares and Maintenance

Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations

6 Pneumonia, pleural disease and respiratory failure

Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis

7 GI bleeding, bowel inflammation and malabsorption

GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS

8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis

Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance

9 Diabetes, thyroid and adrenal disease

Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease

10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies

AKI and chronic kidney disease Potassium and sodium emergencies

11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment

Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care

12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis

Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia

13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology

Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms

14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis

Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment

15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries

Trauma primary survey and adjuncts Chest trauma and immediate threats

16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance

Head injury, imaging and haemorrhage Herniation and spinal cord injury

17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome

Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury

18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care

Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus

19 Aortic Aneurysms & Acute Arterial Limb Ischaemia

Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia

20 Urological Emergencies, Testicular Torsion & Haematuria Investigation

Retention, stones and obstructed infection Scrotal pain and haematuria

21 Preoperative Risk Stratification & Postoperative Surgical Complications

Preoperative assessment and medicines Postoperative complications and prevention

22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening

Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons

23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy

Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding

24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies

Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth

25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis

Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care

26 Contraception, Emergency Contraception & Pregnancy Termination

Contraceptive choice and missed pills Emergency contraception and abortion

27 Australian Cervical Screening Program & Gynaecological Malignancies

Cervical screening and cervical cancer Endometrial and ovarian cancer

28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice

Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening

29 Developmental Milestones, Growth Charts & Failure to Thrive

Developmental milestones Regression, autism and support Faltering growth and developmental comparisons

30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions

Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons

31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis

Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis

32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease

Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up

33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury

Pyloric stenosis Intussusception and dehydration Child protection and injury assessment

34 The Mental State Examination & Suicide Risk Stratification

Mental state examination and psychotic symptoms Suicide formulation and mental health law

35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers

Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT

36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder

Anxiety, panic and agoraphobia OCD and trauma-related disorders

37 Schizophrenia, Acute Psychosis & Antipsychotic Management

Psychosis assessment and antipsychotics Clozapine and severe adverse effects

38 Substance Use Disorders & Acute Withdrawal Syndromes

Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants

39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry

Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry

40 Medicare, PBS, AHPRA & Good Medical Practice Framework

Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications

41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment

Consent, material risks and young people Capacity, refusal and substitute decisions

42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications

Privacy, disclosure and child reporting Driving fitness and threat disclosure

43 First Nations health and preventive care

First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention

44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases

Epidemiology, calculations, bias and surveillance

45 Neurological presentations

Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness

46 Musculoskeletal pain

Back, neck, bone and soft tissue pain

47 Eye presentations

Altered vision and retinal disease Red eye, ocular injury and discharge

48 Ear, nose, throat and oral health

Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis

49 Skin, hair and nails

Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities

50 Breast health and feeding

Breast lumps, discharge and breastfeeding problems

51 Sexual and reproductive presentations

Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction

52 Palliative care and carers

The dying patient, symptoms and carers

53 Eating disorders and personality care

Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care

54 Sleep presentations

Insomnia, snoring and daytime sleepiness

55 Poisoning, resuscitation and environmental emergencies

Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning

56 Communication, rights and professional practice

Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health

57 Genetics, research and donation

Genetic testing, research and organ donation

58 Travel, fever and outbreaks

Fever, travellers and outbreak response

Wernicke disease, opioids and stimulants

Key Takeaways Explain This Topic AI

Do not delay rescue glucose for hypoglycaemia while waiting for thiamine.

Naloxone can wear off before a long-acting opioid.

Opioid agonist treatment reduces harm when delivered through an appropriate clinical programme.

Last updated: October 2026

The Classic Diagnostic Triad

Acute Encephalopathy : Global confusion, disorientation, inattention, apathy, and drowsiness.

Ataxia : Broad-based, unsteady, cerebellar gait ataxia and vestibular dysfunction.

Oculomotor Dysfunction : Horizontal and vertical nystagmus, bilateral lateral rectus palsy (cranial nerve VI palsy), and conjugate gaze palsies.

Critical AMC Clinical Rule : The complete triad is present in fewer than 20% to 30% of patients with confirmed Wernicke encephalopathy. The presence of any single feature (e.g., isolated confusion or isolated ataxia) in an alcohol-dependent or malnourished individual mandates immediate empirical treatment.

Emergency Prophylaxis and Treatment Protocol

Thiamine regimen: Well-nourished uncomplicated withdrawal may use oral prophylaxis. Malnutrition or suspected Wernicke encephalopathy warrants parenteral therapy, with suspected WE commonly treated using high-dose IV thiamine under the protocol. Prophylaxis and treatment are different regimens; imported branded preparations are not a universal Australian requirement.

Thiamine and glucose: Give thiamine before or with carbohydrate when feasible in a deficient patient, but never delay lifesaving glucose for hypoglycaemia. Prolonged carbohydrate delivery without thiamine is dangerous; the rule must not be turned into withholding emergency rescue glucose.

Korsakoff Syndrome : The chronic, irreversible sequela of untreated or inadequately treated Wernicke encephalopathy. Characterized by dense anterograde amnesia (inability to acquire new episodic memories), variable retrograde amnesia, confabulation (fabricating detailed memories to fill memory deficits without deceptive intent), and complete lack of insight.

  • Opioid Misuse: Acute Overdose, Withdrawal & Substitution Therapy
  • Acute Opioid Overdose

Clinical Presentation : The classic opioid toxidrome comprises the triad of:

Respiratory Depression : Bradypnoea (respiratory rate < 8 − 10 breaths/min < 8-10\text{ breaths/min} < 8 − 10 breaths/min ), shallow tidal volumes, hypercapnia, cyanosis, and respiratory arrest.

Pinpoint Pupils (Miosis) : Symmetrical pupillary constriction (note: severe hypoxia or concurrent sympathomimetic ingestion may cause pupillary dilation).

Depressed Level of Consciousness : Stupor, unresponsiveness, or profound coma.

Emergency Resuscitation :

Airway and bag-valve-mask ventilatory support with 100 % 100\% 100% oxygen is the first priority.

Naloxone : Pure competitive mu-opioid receptor antagonist. Administered IV, IM, subcutaneous, or intranasal ( 1.6 − 2 mg 1.6-2\text{ mg} 1.6 − 2 mg IN or 100 − 400 μ g 100-400\ \mu\text{g} 100 − 400 μ g IV).

Titration Goal : Titrate incrementally to restore adequate spontaneous ventilation (respiratory rate > 10 − 12 / min > 10-12/\text{min} > 10 − 12/ min ) and airway protection, not to induce full consciousness. Overzealous dosing precipitates violent acute withdrawal, severe agitation, and non-cardiogenic pulmonary oedema.

After naloxone: Recurrent respiratory depression is possible as naloxone wears off. Long-acting opioid overdose, particularly methadone, needs prolonged monitored admission, often at least 24 hours, and sometimes an infusion. A four-to-six-hour observation rule is not adequate for every opioid.

Opioid Withdrawal Syndrome

Manifestations: Lacrimation, rhinorrhoea, yawning, piloerection ("cold turkey"), mydriasis, diaphoresis, severe diffuse myalgias, abdominal cramps, hyperactive bowel sounds, profuse vomiting, and diarrhoea.

While subjectively agonizing, uncomplicated opioid withdrawal is not directly fatal (unlike alcohol or sedative withdrawal). Symptomatic management includes clonidine (blunts sympathetic hyperactivity), antiemetics (metoclopramide, ondansetron), loperamide, and NSAIDs.

Opioid Substitution Therapy (OST) in Australia

Long-term maintenance therapy reduces illicit opioid use, criminal involvement, blood-borne virus transmission (HIV, hepatitis C), and all-cause mortality.

Long-Acting Injectable Buprenorphine (Buvidal, Sublocade) : Monthly or weekly subcutaneous depot formulations eliminating daily pharmacy attendance, vastly improving treatment adherence and community stability.

  • Stimulant Toxicity: Methamphetamine & Cocaine
  • Pathophysiology and Clinical Presentation

Stimulants (crystal methamphetamine ["ice"], amphetamines, MDMA, cocaine) provoke massive presynaptic release and blockade of reuptake of noradrenaline, dopamine, and serotonin.

Sympathomimetic Toxidrome : Marked bilateral pupillary dilation (mydriasis), profuse diaphoresis, hyperpyrexia, sinus tachycardia, severe arterial hypertension, tachypnoea, tremor, hyperreflexia, extreme psychomotor agitation, persecutory paranoia, and tactile formication ("ice bugs" / delusional parasitosis).

Life-Threatening Complications : Hypertensive encephalopathy, acute myocardial infarction, aortic dissection, intracranial haemorrhage, severe hyperthermia ( > 40.0 ∘ C > 40.0^\circ\text{C} > 40. 0 ∘ C ), rhabdomyolysis, and renal failure.

Emergency Management

Environmental Control : Quiet, low-stimulus environment; security containment if violent.

First-Line Pharmacotherapy : Benzodiazepines (e.g., diazepam 5 − 10 mg 5-10\text{ mg} 5 − 10 mg IV or 10 − 20 mg 10-20\text{ mg} 10 − 20 mg orally, repeated every 10 to 15 minutes). Benzodiazepines enhance GABA inhibition, directly suppressing central sympathetic outflow, reducing agitation, lowering heart rate and blood pressure, and halting hypermetabolic heat production.

Stimulant toxicity: Benzodiazepines and supportive care are first-line for agitation and sympathetic activation. Persistent cardiovascular toxicity needs expert treatment; beta-blockers are not the routine first step. The unopposed-alpha concern should not be described as an inevitable fatal effect of every beta-blocker, and combined alpha/beta agents may have selected specialist roles.

Clinical Comparison Table: Intoxication & Withdrawal Toxidromes

Alcohol : Intoxication Presentation: Intoxication: ataxia and possible respiratory depression; Withdrawal Presentation: Withdrawal: tremor, autonomic symptoms, seizures or delirium; First-Line Management Priorities: Benzodiazepines under protocol; thiamine without delaying emergency glucose

Opioids : Intoxication Presentation: Pinpoint pupils (miosis), bradypnoea, coma (hypoventilation); Withdrawal Presentation: Mydriasis, rhinorrhoea, piloerection, cramps, diarrhoea; First-Line Management Priorities: Titrated IV/IN naloxone for overdose; buprenorphine/methadone for OST

For opioid overdose, improvement after naloxone does not establish sustained safety. Continue respiratory observation and reassess the opioid formulation and co-ingestants. A long-acting opioid can outlast the antagonist; recurrent sedation requires prompt reassessment, additional treatment and an appropriate monitored setting.

Primary references (checked 7 October 2026): Australian alcohol treatment guidance .